These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 16918491

  • 1. Glycogen phosphorylase inhibitors.
    Henke BR, Sparks SM.
    Mini Rev Med Chem; 2006 Aug; 6(8):845-57. PubMed ID: 16918491
    [Abstract] [Full Text] [Related]

  • 2. Prolonged inhibition of glycogen phosphorylase in livers of Zucker Diabetic Fatty rats models human glycogen storage diseases.
    Floettmann E, Gregory L, Teague J, Myatt J, Hammond C, Poucher SM, Jones HB.
    Toxicol Pathol; 2010 Apr; 38(3):393-401. PubMed ID: 20215584
    [Abstract] [Full Text] [Related]

  • 3. Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition.
    Goyard D, Kónya B, Chajistamatiou AS, Chrysina ED, Leroy J, Balzarin S, Tournier M, Tousch D, Petit P, Duret C, Maurel P, Somsák L, Docsa T, Gergely P, Praly JP, Azay-Milhau J, Vidal S.
    Eur J Med Chem; 2016 Jan 27; 108():444-454. PubMed ID: 26708111
    [Abstract] [Full Text] [Related]

  • 4. The experimental type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction.
    Baker DJ, Greenhaff PL, MacInnes A, Timmons JA.
    Diabetes; 2006 Jun 27; 55(6):1855-61. PubMed ID: 16731853
    [Abstract] [Full Text] [Related]

  • 5. Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus.
    Treadway JL, Mendys P, Hoover DJ.
    Expert Opin Investig Drugs; 2001 Mar 27; 10(3):439-54. PubMed ID: 11227044
    [Abstract] [Full Text] [Related]

  • 6. Advances in glycogen phosphorylase inhibitor design.
    Oikonomakos NG, Somsák L.
    Curr Opin Investig Drugs; 2008 Apr 27; 9(4):379-95. PubMed ID: 18393105
    [Abstract] [Full Text] [Related]

  • 7. Glycogen phosphorylase inhibitors: a patent review (2013 - 2015).
    Donnier-Maréchal M, Vidal S.
    Expert Opin Ther Pat; 2016 Apr 27; 26(2):199-212. PubMed ID: 26666989
    [Abstract] [Full Text] [Related]

  • 8. Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitors.
    Ogawa AK, Willoughby CA, Bergeron R, Ellsworth KP, Geissler WM, Myers RW, Yao J, Harris G, Chapman KT.
    Bioorg Med Chem Lett; 2003 Oct 20; 13(20):3405-8. PubMed ID: 14505637
    [Abstract] [Full Text] [Related]

  • 9. New hepatic targets for glycaemic control in diabetes.
    Agius L.
    Best Pract Res Clin Endocrinol Metab; 2007 Dec 20; 21(4):587-605. PubMed ID: 18054737
    [Abstract] [Full Text] [Related]

  • 10. Glycogen phosphorylase as a molecular target for type 2 diabetes therapy.
    Oikonomakos NG.
    Curr Protein Pept Sci; 2002 Dec 20; 3(6):561-86. PubMed ID: 12470212
    [Abstract] [Full Text] [Related]

  • 11. Intervention of hepatic glucose production. Small molecule regulators of potential targets for Type 2 diabetes therapy.
    Barf T.
    Mini Rev Med Chem; 2004 Oct 20; 4(8):897-908. PubMed ID: 15544551
    [Abstract] [Full Text] [Related]

  • 12. Glucose analog inhibitors of glycogen phosphorylases as potential antidiabetic agents: recent developments.
    Somsák L, Nagya V, Hadady Z, Docsa T, Gergely P.
    Curr Pharm Des; 2003 Oct 20; 9(15):1177-89. PubMed ID: 12769745
    [Abstract] [Full Text] [Related]

  • 13. Novel therapeutics based on inhibiting the interaction of glycogen phosphorylase and GL-subunit of glycogen-associated protein phosphatase 1: WO2009127723.
    Zhang L, Liu H.
    Expert Opin Ther Pat; 2010 Jul 20; 20(7):969-73. PubMed ID: 20367521
    [Abstract] [Full Text] [Related]

  • 14. New inhibitors of glycogen phosphorylase as potential antidiabetic agents.
    Somsák L, Czifrák K, Tóth M, Bokor E, Chrysina ED, Alexacou KM, Hayes JM, Tiraidis C, Lazoura E, Leonidas DD, Zographos SE, Oikonomakos NG.
    Curr Med Chem; 2008 Jul 20; 15(28):2933-83. PubMed ID: 19075645
    [Abstract] [Full Text] [Related]

  • 15. Insulin sensitivity is modified by a glycogen phosphorylase inhibitor: glucopyranosylidene-spiro-thiohydantoin in streptozotocin-induced diabetic rats.
    Docsa T, Marics B, Németh J, Hüse C, Somsák L, Gergely P, Peitl B.
    Curr Top Med Chem; 2015 Jul 20; 15(23):2390-4. PubMed ID: 26095241
    [Abstract] [Full Text] [Related]

  • 16. Computation as a tool for glycogen phosphorylase inhibitor design.
    Hayes JM, Leonidas DD.
    Mini Rev Med Chem; 2010 Oct 20; 10(12):1156-74. PubMed ID: 20716053
    [Abstract] [Full Text] [Related]

  • 17. Dual-action hypoglycemic and hypocholesterolemic agents that inhibit glycogen phosphorylase and lanosterol demethylase.
    Harwood HJ, Petras SF, Hoover DJ, Mankowski DC, Soliman VF, Sugarman ED, Hulin B, Kwon Y, Gibbs EM, Mayne JT, Treadway JL.
    J Lipid Res; 2005 Mar 20; 46(3):547-63. PubMed ID: 15604516
    [Abstract] [Full Text] [Related]

  • 18. Phytogenic Polyphenols as Glycogen Phosphorylase Inhibitors: The Potential of Triterpenes and Flavonoids for Glycaemic Control in Type 2 Diabetes.
    Leonidas DD, Hayes JM, Kato A, Skamnaki VT, Chatzileontiadou DS, Kantsadi AL, Kyriakis E, Chetter BA, Stravodimos GA.
    Curr Med Chem; 2017 Mar 20; 24(4):384-403. PubMed ID: 27855623
    [Abstract] [Full Text] [Related]

  • 19. Effects of hyperglycemia on hepatic gluconeogenic flux during glycogen phosphorylase inhibition in the conscious dog.
    Edgerton DS, Cardin S, Neal D, Farmer B, Lautz M, Pan C, Cherrington AD.
    Am J Physiol Endocrinol Metab; 2004 Apr 20; 286(4):E510-22. PubMed ID: 14644767
    [Abstract] [Full Text] [Related]

  • 20. Antihyperglycemic effect of aqueous and ethanolic extracts of Gongronema latifolium leaves on glucose and glycogen metabolism in livers of normal and streptozotocin-induced diabetic rats.
    Ugochukwu NH, Babady NE.
    Life Sci; 2003 Aug 29; 73(15):1925-38. PubMed ID: 12899918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.